NetworkNewsBreaks – Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) Shares Soar on New Coverage of ThyraMIR® Test by Oxford Health Plans
Shares of Interpace Diagnostics Group (NASDAQ: IDXG) are 29.5% higher mid-day, moving on volume of 24.2 million, after the company this morning said that its ThyraMIR® test for indeterminate thyroid nodules will now be covered by Oxford Health Plans, effective August 1, 2017. Oxford Health Plans is a UnitedHealthcare company that offers health care benefits to employers and individuals predominantly in the heavily populated tri-state region of New York, New Jersey, and Connecticut. The addition of Oxford’s members brings the total lives covered to 250 million nationwide. “We are pleased that Oxford has joined the growing list of health plans…







